From: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges
Characteristics of the patients | |
---|---|
Number of patients | 14 |
Sex, n, Female/Male | 5/9 |
Age, years (mean ± standard deviation) | 52.6 ± 17.83 |
Treatment characteristics | |
Median number of treatments per patient | 2.5 |
TPE indication (N = 47), n (%) | |
Thrombotic microangiopathy | 25 (53) |
Acute humoral rejection | 8 (17) |
ANCA-associated vasculitis | 7 (15) |
Antiglomerular basal membrane vasculitis | 3 (6) |
Cryoglobulinemia associated vasculitis | 2 (4) |
Neurological diseases | 2 (4) |
TPE during active bleeding, n (%) | 8 (17) |